05/14/2025
5:21 PM | Atea Pharmaceuticals (Subject)
Sommadossi Jean-Pierre (Filed by)
| Form SCHEDULE 13G/A | |
05/12/2025
3:45 PM | Atea Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2025
4:00 PM | Atea Pharmaceuticals (Filer)
| Form DEF 14A | |
04/23/2025
7:14 PM | Atea Pharmaceuticals (Subject)
BlackRock, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
04/17/2025
11:23 AM | Atea Pharmaceuticals (Subject)
Radoff Bradley Louis (Filed by)
| Form SCHEDULE 13D/A | |
04/17/2025
7:06 AM | Atea Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2025
3:50 PM | Atea Pharmaceuticals (Filer)
| Form DEFA14A | |
04/01/2025
8:21 AM | Atea Pharmaceuticals (Filer)
| Form DEFA14A | |
04/01/2025
8:19 AM | Atea Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2025
4:15 PM | Atea Pharmaceuticals (Filer)
| Form DEFA14A | |
03/26/2025
1:30 PM | Atea Pharmaceuticals (Subject)
Radoff Bradley Louis (Filed by)
| Form DFAN14A | |
Get the Latest News and Ratings for AVIR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Atea Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
03/24/2025
5:16 AM | Atea Pharmaceuticals (Filer)
| Form DEFA14A | |
03/24/2025
5:10 AM | Atea Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2025
10:58 AM | Atea Pharmaceuticals (Subject)
Radoff Bradley Louis (Filed by)
| Form SCHEDULE 13D/A | |
03/06/2025
3:45 PM | Atea Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2025
8:27 AM | Atea Pharmaceuticals (Subject)
Radoff Bradley Louis (Filed by)
| Form SCHEDULE 13D | |
02/24/2025
5:52 PM | Atea Pharmaceuticals (Issuer)
Kirsch Arthur S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
5:47 PM | Atea Pharmaceuticals (Issuer)
Kirsch Arthur S (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/24/2025
7:17 AM | Atea Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
11:47 AM | Atea Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/04/2025
5:00 PM | Atea Pharmaceuticals (Issuer)
Foster Wayne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
5:00 PM | Atea Pharmaceuticals (Issuer)
Sommadossi Jean-Pierre (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
5:00 PM | Atea Pharmaceuticals (Issuer)
Corcoran Andrea (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
5:00 PM | Atea Pharmaceuticals (Issuer)
Horga Maria Arantxa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
5:00 PM | Atea Pharmaceuticals (Issuer)
Vavricka John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
5:00 PM | Atea Pharmaceuticals (Issuer)
Hammond Janet MJ (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2025
1:30 PM | Atea Pharmaceuticals (Issuer)
BERGER FRANKLIN M (Reporting)
| Form 4/A | |
01/17/2025
7:03 AM | Atea Pharmaceuticals (Issuer)
BERGER FRANKLIN M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
8:50 AM | Atea Pharmaceuticals (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SCHEDULE 13D | |
12/12/2024
5:00 PM | Atea Pharmaceuticals (Issuer)
BERGER FRANKLIN M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
4:17 PM | Atea Pharmaceuticals (Subject)
BERGER FRANKLIN M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/19/2024
11:15 PM | Atea Pharmaceuticals (Filer)
| Form EFFECT | |
11/15/2024
9:34 AM | Atea Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
11/07/2024
3:58 PM | Atea Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/07/2024
3:41 PM | Atea Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
3:27 PM | Atea Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
7:02 PM | Atea Pharmaceuticals (Issuer)
Sommadossi Jean-Pierre (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2024
3:22 PM | Atea Pharmaceuticals (Subject)
JPM Partners LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:09 PM | Atea Pharmaceuticals (Subject)
JPM Partners LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/17/2024
3:16 PM | Atea Pharmaceuticals (Subject)
JPM Partners LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
3:45 PM | Atea Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Is Elon's empire crumbling? (Ad) The Tesla Shock Nobody Sees Coming
While headlines scream "Tesla is doomed"...
Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs.
One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd. Click here to see the Tesla shock that could blindside everyone. |
08/07/2024
3:15 PM | Atea Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
4:59 PM | Atea Pharmaceuticals (Issuer)
Polsky Bruce (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
5:00 PM | Atea Pharmaceuticals (Issuer)
Lucidi Bruno (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
5:06 PM | Adams Jerome M. (Reporting)
Atea Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
5:08 PM | Atea Pharmaceuticals (Issuer)
BERGER FRANKLIN M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
5:12 PM | Atea Pharmaceuticals (Issuer)
Duncan Barbara Gayle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:54 PM | Atea Pharmaceuticals (Issuer)
Murphy Polly A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:21 PM | Atea Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
4:32 PM | Atea Pharmaceuticals (Subject)
Polsky Bruce (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Buy AVIR Stock Free AVIR Stock Alerts